W.R. Berkley Corp’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-119,047
Closed -$1.19M 390
2022
Q3
$1.19M Hold
119,047
0.06% 319
2022
Q2
$1.18M Hold
119,047
0.06% 315
2022
Q1
$1.17M Buy
119,047
+79,149
+198% +$779K 0.06% 320
2021
Q4
$389K Buy
+39,898
New +$389K 0.02% 487